{{Drugbox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 443222760
| IUPAC_name = ''N''-(2-Chloroethyl)-''N'''-(4-methylcyclohexyl)-''N''-nitrosourea
| image = Semustine.svg
| width = 200

<!--Clinical data-->
| tradename =  
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B / C / D / X -->
| pregnancy_category =  
| legal_AU = <!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled-->
| legal_CA = <!-- Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = <!-- GSL, P, POM, CD, or Class A, B, C -->
| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V -->
| legal_status =  
| routes_of_administration =

<!--Pharmacokinetic data-->
| bioavailability =  
| protein_bound =  
| metabolism =  
| elimination_half-life =  
| excretion =

<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 13909-09-6
| ATC_prefix = L01
| ATC_suffix = AD03
| PubChem = 5198
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank =  
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 6YY7T1T567
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D05822
| ChEBI_Ref = {{ebicite|changed|EBI}}
| ChEBI = 6863
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}
| ChemSpiderID = 5009

<!--Chemical data-->
| C=10 | H=18 | Cl=1 | N=3 | O=2 
| molecular_weight = 247.72 g/mol
|  smiles = CC1CCC(CC1)NC(=O)N(CCCl)N=O
|  StdInChI_Ref = {{stdinchicite|changed|chemspider}}
| StdInChI = 1S/C10H18ClN3O2/c1-8-2-4-9(5-3-8)12-10(15)14(13-16)7-6-11/h8-9H,2-7H2,1H3,(H,12,15)
|  StdInChIKey_Ref = {{stdinchicite|changed|chemspider}}
| StdInChIKey = FVLVBPDQNARYJU-UHFFFAOYSA-N
}}

'''Semustine''' is a drug used in [[chemotherapy]].<ref>{{Cite journal 
| title = Radiation therapy and fluorouracil with or without semustine for the treatment of patients with surgical adjuvant adenocarcinoma of the rectum. Gastrointestinal Tumor Study Group 
| journal = Journal of Clinical Oncology 
| volume = 10 
| issue = 4 
| pages = 549â€“557 
| year = 1992 
| pmid = 1548520
| doi=10.1200/jco.1992.10.4.549
}}</ref>
It is structurally similar to [[lomustine]], being distinguished from it only by an additional [[methyl]] group. It has been taken off the drug market for investigation of its cancerous effects, rated as [[IARC Group 1 carcinogen]] or a known carcinogen.<ref>http://www.cancer.org/cancer/cancercauses/othercarcinogens/generalinformationaboutcarcinogens/known-and-probable-human-carcinogens, Known and Probable Human Carcinogens, American Cancer Society</ref>

==References==
{{reflist}}

{{Chemotherapeutic agents}}

[[Category:Alkylating antineoplastic agents]]
[[Category:IARC Group 1 carcinogens]]
[[Category:Nitrosamines]]
[[Category:Nitrosoureas]]
[[Category:Organochlorides]]
[[Category:Withdrawn drugs]]

{{antineoplastic-drug-stub}}